Cara Therapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Cara Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cara Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cara Therapeutics by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $158k | 173k | 0.91 |
| 2023-12-31 | $125k | 168k | 0.74 |
| 2023-09-30 | $110k | 66k | 1.68 |
| 2022-12-31 | $1.1M | 102k | 10.74 |
| 2022-09-30 | $306k | 33k | 9.36 |
| 2022-06-30 | $433k | 47k | 9.14 |
| 2021-06-30 | $10M | 732k | 14.27 |
| 2021-03-31 | $1.4M | 64k | 21.71 |
| 2020-12-31 | $535k | 35k | 15.13 |
| 2020-09-30 | $2.1M | 164k | 12.73 |
| 2019-12-31 | $1.0M | 62k | 16.11 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management